Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.720
-0.010 (-0.58%)
At close: Dec 5, 2025, 4:00 PM EST
1.740
+0.020 (1.16%)
After-hours: Dec 5, 2025, 6:49 PM EST
Climb Bio Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Climb Bio stock have an average target of 9.00, with a low estimate of 8.00 and a high estimate of 10. The average target predicts an increase of 423.26% from the current stock price of 1.72.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 16, 2025.
Analyst Ratings
The average analyst rating for Climb Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 2 | 2 |
| Buy | 1 | 1 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 3 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 16, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +365.12% | Oct 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +423.26% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +365.12% | Sep 30, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +306.98% | Sep 22, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.84
from -1.53
EPS Next Year
-0.89
from -0.84
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.85 | -0.78 | ||
| Avg | -0.84 | -0.89 | ||
| Low | -0.81 | -0.95 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.